208 related articles for article (PubMed ID: 27568453)
1. Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial.
Beauchet O; Barden J; Liu-Ambrose T; Chester VL; Annweiler C; Szturm T; Grenier S; Léonard G; Bherer L; Allali G;
Drugs Aging; 2016 Sep; 33(9):665-73. PubMed ID: 27568453
[TBL] [Abstract][Full Text] [Related]
2. Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study.
Beauchet O; Launay CP; Allali G; Watfa G; Gallouj K; Herrmann FR; Annweiler C
BMC Neurol; 2013 Nov; 13():184. PubMed ID: 24261605
[TBL] [Abstract][Full Text] [Related]
3. Body position and motor imagery strategy effects on imagining gait in healthy adults: Results from a cross-sectional study.
Beauchet O; Launay CP; Sekhon H; Gautier J; Chabot J; Levinoff EJ; Allali G
PLoS One; 2018; 13(3):e0191513. PubMed ID: 29543816
[TBL] [Abstract][Full Text] [Related]
4. Association between dual task-related decrease in walking speed and real versus imagined Timed Up and Go test performance.
Bridenbaugh SA; Beauchet O; Annweiler C; Allali G; Herrmann F; Kressig RW
Aging Clin Exp Res; 2013 Jun; 25(3):283-9. PubMed ID: 23740587
[TBL] [Abstract][Full Text] [Related]
5. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.
Beauchet O; Launay CP; Allali G; Herrmann FR; Annweiler C
Drugs Aging; 2014 May; 31(5):363-72. PubMed ID: 24683126
[TBL] [Abstract][Full Text] [Related]
6. Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis.
Beauchet O; Launay CP; Allali G; Annweiler C
CNS Drugs; 2014 Jun; 28(6):513-8. PubMed ID: 24806974
[TBL] [Abstract][Full Text] [Related]
7. Gait Performance and Use of Mental Imagery as a Measure of Disease Progression in Amyotrophic Lateral Sclerosis.
Iancu Ferfoglia R; Heritier Barras AC; Pollak P; Janssens JP; Pradat PF; Allali G
Eur Neurol; 2016; 75(3-4):109-12. PubMed ID: 26900935
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
Wong CW
Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
[TBL] [Abstract][Full Text] [Related]
10. Imagined Timed Up & Go test: a new tool to assess higher-level gait and balance disorders in older adults?
Beauchet O; Annweiler C; Assal F; Bridenbaugh S; Herrmann FR; Kressig RW; Allali G
J Neurol Sci; 2010 Jul; 294(1-2):102-6. PubMed ID: 20444477
[TBL] [Abstract][Full Text] [Related]
11. Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
Beauchet O; Launay CP; Montero-Odasso M; Annweiler C; Allali G
Curr Alzheimer Res; 2015; 12(8):761-71. PubMed ID: 26159199
[TBL] [Abstract][Full Text] [Related]
12. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
13. Gait and motor imagery of gait in early schizophrenia.
Lallart E; Jouvent R; Herrmann FR; Beauchet O; Allali G
Psychiatry Res; 2012 Aug; 198(3):366-70. PubMed ID: 22445069
[TBL] [Abstract][Full Text] [Related]
14. Drugs for cognitive loss and dementia.
Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
[TBL] [Abstract][Full Text] [Related]
15. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
16. Older Adults with Fear of Falling Show Deficits in Motor Imagery of Gait.
Sakurai R; Fujiwara Y; Yasunaga M; Suzuki H; Sakuma N; Imanaka K; Montero-Odasso M
J Nutr Health Aging; 2017; 21(6):721-726. PubMed ID: 28537339
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
18. Motor imagery of gait: a new way to detect mild cognitive impairment?
Beauchet O; Launay CP; Sejdić E; Allali G; Annweiler C
J Neuroeng Rehabil; 2014 Apr; 11():66. PubMed ID: 24742021
[TBL] [Abstract][Full Text] [Related]
19. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.
Shimura H; Saiko A; Hayashi A; Hattori N; Urabe T
BMC Neurol; 2021 Feb; 21(1):61. PubMed ID: 33568083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
